Dr. Eva Pisa has diverse leadership experience across all stages of diagnostic and life science commercialization and product development, from both start-ups and large corporations.
Eva founded Sangtec Molecular Diagnostics in 2001 and led the company as CEO to profitability and divesture to Cepheid 2007. She later joined Roche Diagnostics where she led global teams and major development projects over 12 years before retiring as a member of the Executive Committee and SVP Life Cycle Leader with global responsibility for clinical chemistry. She is currently a board member of several biotechnology companies.
Eva earned her Ph.D. in Immunology from the Karolinska Institute in 1993 and completed an MBA at Heriot-Watt University in 2003.
